Mark Goldberg

Mark Goldberg

DirectoratCrescent Biopharma· In the 2023 proxy

Mark Goldberg sits on 5 public boards.

Experience

  1. Crescent BiopharmaPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -94%
  2. Avacta GroupPublic company
    • Director? – PresentNo stock prices for these years
  3. Blueprint Medicines CorporationPublic company
    • Director? – PresentNo stock prices for these years
  4. Audentes Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  5. Idera PharmaceuticalsPublic company
    • Director? – PresentNo stock prices for these years
  6. ImmunoGen, Inc.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?